Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Aequus Pharmaceuticals Inc (AQSZF)

Aequus Pharmaceuticals Inc (AQSZF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AQSZF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0205 +28.29%
on 11/28/22
0.0320 -17.81%
on 11/28/22
-0.0030 (-10.24%)
since 11/02/22
3-Month
0.0205 +28.29%
on 11/28/22
0.0566 -53.53%
on 09/12/22
-0.0157 (-37.38%)
since 09/02/22
52-Week
0.0013 +1,923.08%
on 06/21/22
0.0998 -73.65%
on 06/27/22
-0.0539 (-67.21%)
since 12/02/21

Most Recent Stories

More News
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.

VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 – 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Resumes Trading on TSX Venture Exchange

VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) announces that further to our news...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products

VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Provides General Update and Reports Record 2021 Financial Results

Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Announces Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Announces Short Term Loan

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)
Aequus Announces Director Resignation

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical...

AQS.VN : 0.030 (unch)
AQSZF : 0.0263 (-17.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0263
2nd Resistance Point 0.0263
1st Resistance Point 0.0263
Last Price 0.0263
1st Support Level 0.0263
2nd Support Level 0.0263
3rd Support Level 0.0263

See More

52-Week High 0.0998
Fibonacci 61.8% 0.0622
Fibonacci 50% 0.0505
Fibonacci 38.2% 0.0389
Last Price 0.0263
52-Week Low 0.0013

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar